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Intestinal epithelial homeostasis requires contin-
uous renewal supported by stem cells located in
the base of the crypt. Disruption of this balance re-
sults in failure to regenerate and initiates tumori-
genesis. The b-catenin and Yap pathways in Lgr5+
stem cells have been shown to be central to this
process. However, the precise mechanisms by
which these signaling molecules are regulated in
the stem cell population are not totally understood.
Protein kinase C z (PKCz) has been previously
demonstrated to be a negative regulator of intesti-
nal tumorigenesis. Here, we show that PKCz sup-
presses intestinal stem cell function by promoting
the downregulation of b-catenin and Yap through
direct phosphorylation. PKCz deficiency results in
increased stem cell activity in organoid cultures
and in vivo, accounting for the increased tumori-
genic and regenerative activity response of Lgr5+-
specific PKCz-deficient mice. This demonstrates
that PKCz is central to the control of stem cells in
intestinal cancer and homeostasis.
INTRODUCTION
The intestinal epithelium displays a high renewal potential due
in large part to the activity of intestinal stem cells (ISCs)
(Clevers, 2013). Targeting of the Lgr5 marker gene has recently
led to the identification of a type of stem cell located in the
mouse small intestine at the bottom of the crypt (Barker
et al., 2007, 2009). They give rise to the transit-amplifying
(TA) crypt compartment, in which TA cells divide and migrate
upward toward the crypt-villus junction (Clevers, 2013). When
committed TA cells reach this junction, they rapidly differentiate
while continuing their upward migration (Clevers, 2013). This740 Cell Reports 10, 740–754, February 10, 2015 ª2015 The Authorsstem cell population has been shown to be very sensitive to
transformation by adenomatous polyposis coli (APC) mutations
that rapidly lead to adenoma formation (Barker et al., 2009). In
contrast, TA cells, and more differentiated cells within the villus,
although also capable of adenoma formation, will only do so af-
ter long latency periods (Schwitalla et al., 2013). This suggests
that stem cells are the most common origin of intestinal cancer
(Barker et al., 2009). Furthermore, Lgr5-expressing cells have
been detected within experimental adenomas, and their func-
tion has been shown by lineage-tracing assays. This supports
the idea that normal tissue stem cells can contribute to cancer
initiation and progression and is consistent with the cancer
stem cell theory (Schepers et al., 2012). If ISCs are the target
of tumor-initiation factors, we can predict that increasing the
number or proliferative activity of these cells will increase the
risk of intestinal neoplasms as well as hamper their treatment.
Therefore, a better understanding of the signaling cascades
that regulate stem cell signaling is essential for the design of
new and more efficacious therapies for intestinal tumors, as
well as tissue regeneration after injury.
We have addressed this fundamental biological problem
in the context of protein kinase C z (PKCz) deficiency. PKCz
and PKCl/i constitute the atypical protein kinase C (aPKC)
family. Both aPKCs have been implicated in oncogenic trans-
formation (Moscat et al., 2009). A number of studies support
the clinical relevance of PKCz as a tumor suppressor
in several tissues, including the intestine (Galvez et al., 2009;
Ma et al., 2013). Thus, our own studies demonstrated
that PKCz is downregulated in human colorectal cancers as
compared to normal colon tissue and is underexpressed in
cancers progressing to metastasis (Ma et al., 2013). Interest-
ingly, an inactivation mutation in PKCz (S514F) has been iden-
tified in human colon cancers (Galvez et al., 2009; Wood et al.,
2007). Our most recent studies demonstrated that PKCz defi-
ciency promotes the plasticity necessary for intestinal cancer
cells to reprogram their metabolism in order to survive in
the absence of glucose and that the total-body loss of PKCz
in mice results in enhanced intestinal tumorigenesis. Those
Figure 1. PKCz Represses Intestinal Stem
Cell Activity
(A) PKCz mRNA levels in intestinal epithelial cells
from different intestinal regions (n = 4).
(B) Lgr5-GFP+ cells sorting from control and Lgr5-
EGFP-ires-CreERT2 intestine.
(C) PKCz and Lgr5 mRNA levels in the different
sorted populations (n = 4).
(D) Confocal immunofluorescence of PKCz and
GFP in Lgr5-EGFP-ires-CreERT2 intestinal sec-
tions. Scale bars represent 25 mm.
(E) Intestinal crypt organoids from WT and PKCz
KO mice after 3 days in culture.
(F and G) Quantification of number of organoids (F)
and organoid structural complexity (G) of experi-
ment shown in (E); n = 6.
(H–J) Quantitative analysis of ISC markers in or-
ganoids (n = 3) (H), intestinal epithelial cells (n = 6)
(I), and small intestine fromWT and PKCz KOmice
(n = 6) (J).
(K) LacZ stained sections of small intestine from
Lgr5-WT and Lgr5-PKCz KO mice 5 days after
tamoxifen injection.
(L and M) Quantification of LacZ-stained cells in
the crypt-villus unit (L) and number of blue-labeled
intestinal crypts (M). Counting of at least 20 fields
of view per mouse (n = 3 mice).
Scale bars represent 100 mm. Results are pre-
sented asmean ±SEM. *p < 0.05, **p < 0.01, ***p <
0.001. See also Figure S1.results unveiled a critical role for PKCz as a tumor suppressor
in cells metabolically stressed during tumor progression (Ma
et al., 2013). However, it remains to be determined whether
PKCz is important in stem cell function related to tumorigen-
esis and under noncancer conditions, such as during tissue
regeneration.Cell Reports 10, 740–754,RESULTS
Loss of PKCz Results in Increased
Intestinal Stem Cell Activity
As a first step in exploring the role of
PKCz in ISCs, we used the Lgr5-EGFP-
ires-CreERT2 knockin allele mouse strain
crossed with Rosa26-LacZ reporter mice
to generate Lgr5Cre-Rosa26-LacZ mice.
In this mouse model, Lgr5+ cells were
GFP labeled and the Lgr5Cre reporter
was activated by injection of tamoxifen.
This strategy allows for the purification
of Lgr5+ cells by sorting using GFP as
the marker, as well as the in vivo tracking
of the subsequent fate of the progeny of
these cells by X-gal staining of intestinal
tissue (Barker et al., 2007, 2009). Of
note, we found that PKCz was expressed
both in the small intestine and in the colon
and that its levels were specially enriched
in ileum as compared to duodenum or
jejunum (Figure 1A). To determine itsexpression in ISCs, we sorted GFP-positive epithelial cells
from crypts isolated from ileum of Lgr5-EGFP-ires-CreERT2
mice. Fluorescence-activated cell sorting analysis distinguished
an LGR5-GFP-high (GFPhi) cell population, corresponding to the
active stem cell pool, and an LGR5-GFP-low (GFPlo) fraction that
contains the immediate/early non-stem cell progeny (Figure 1B).February 10, 2015 ª2015 The Authors 741
Figure 2. PKCz Deficiency in Lgr5+ Cells Leads the Improved Intestinal Regeneration
(A) Experimental design.
(B) Macroscopic (left) and magnified (for duodenum, jejunum, and ileum) images of LacZ-stained small intestine in Lgr5-PKCzWT/WT and Lgr5-PKCz/ mice
3 days after IR. Scale bars represent 1 cm (macroscopic) and 1 mm (magnified).
(C–E) LacZ staining of small intestine; scale bars represent 100 mm (C); quantification of the number of LacZ positive crypts (D) and GFP staining labeling Lgr5+
cells; scale bars represent 25 mm (E) from irradiated Lgr5-PKCzWT/WT and Lgr5-PKCz/ mice.
(F) H&E-stained sections of small intestine from Lgr5-PKCzWT/WT and Lgr5-PKCz/ mice 3 days after IR. Scale bars represent 25 mm.
(legend continued on next page)
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These two GFP-positive populations were sorted and separated
from the LGR5-GFP-negative fraction (GFPne), after which
mRNA was extracted from the different cell populations and
analyzed by qRT-PCR to determine PKCz content. Interestingly,
PKCz was expressed in the three cell fractions and highly en-
riched in the GFPlo cell population (Figure 1C). Consistent with
these results, immunofluorescence staining of PKCz showed
apical localization in epithelial cells in the crypt, including coloc-
alization with crypt bottom stem cells with strong GFP expres-
sion (Figure 1D). The fact that PKCz was relatively enriched in
the GFPlo population as compared to the GFPhi would suggest
its potential stem cell-suppressor activity. Therefore, to deter-
mine whether PKCz deficiency in fact influences ISC activity,
we carried out experiments in an organoid culture model system
using intestinal crypts from wild-type (WT) or total-body PKCz
knockout (PKCz KO) mice. This system assesses the activity of
ISCs on the basis of their ability to drive the formation of organo-
ids. Interestingly, PKCz deficiency led to increases in both the
number and complexity (higher number of lobes) of intestinal or-
ganoids (Figures 1E–1G), strongly indicating that PKCz’s role is
to restrain the activity of ISCs. Consistent with this, gene tran-
scripts of the stem cell markers Lgr5 and Bmi1 were upregulated
in PKCz-deficient organoids as compared to WT controls (Fig-
ure 1H). Similar increases in thesemarkers were found in isolated
intestinal epithelial cells (IECs) and in extracts from small intes-
tine of PKCz KO mice (Figures 1I and 1J).
We next used the Lgr5Cre-Rosa26-LacZ knockin model
described above, but bred into a PKCz KO background. In
this system, injection of tamoxifen allows the stem cell progeny
to be followed by X-gal staining. Notably, PKCz KO intestines
had increased numbers of LacZ-stained cells, as compared
with WT controls (Figures 1K–1M). Staining appeared along
the flanks of the crypt-villus units of PKCz-deficient intestines
at day 5 after tamoxifen injection to a greater extent than in
WT mice (Figures 1K–1M). This is in agreement with the idea
that the loss of PKCz favors increased stem cell activity in the
intestine. Interestingly, staining of these samples with markers
of differentiated cell populations such as enterocytes (Fig-
ure S1A), Goblet (Figure S1B), or Paneth (Figure S1C) cells did
not show differences between the two mouse genotypes.
Also, no major alterations were detected in polarity in PKCz
KO intestines when several markers were analyzed by qRT-
PCR or by immunohistochemistry of E-cadherin, Na/K-ATPase,
or ZO-1 (Figures S1D–S1F), supporting the notion that the stem
cell repressor activity of PKCz is not related to regulation of
intestine epithelial cell polarity.
PKCz Deficiency Promotes Intestinal Regeneration
Stem cells play a central role in intestinal regeneration after acute
damage, which can be modeled by irradiation (IR)-induced abla-
tion of the intestinal epithelium. To definitively establish the role
of PKCz in the Lgr5+ stem cell population and to rule out the hy-
pothetical contribution of cells other than Lgr5+, we generated(G–I) Number of crypts per millimeter (G), crypt size (H), and villus length (I).
(J and K) Images (J) and quantification (K) of Ki67 staining of Lgr5-PKCzWT/WT an
(L and M) Images (L) and quantification (M) of Sox9 staining of small intestine fro
Scale bars represent 25 mm. Results are presented as mean ± SEM. Counts are
Cemice with PKCz KO only in the Lgr5+ stem cell population. For
this, we crossed Lgr5Cre-Rosa26-LacZ mice with a mouse line
with floxed PKCz alleles (PKCzfl/fl). In the resulting progeny,
termed Lgr5-PKCzfl/fl, PKCz was deleted selectively in Lgr5+
cells upon tamoxifen injection, thus generating Lgr5-PKCz/
mice. As above, this manipulation also made possible the in vivo
tracking and determination of the subsequent fate of these
Lgr5+ cells by X-gal staining. Therefore, Lgr5-PKCzWT/WT and
Lgr5-PKCzfl/fl mice were injected with tamoxifen and irradiated
7 days thereafter. Afterward, they were allowed to recover and
analyzed 3 days post-IR (Figure 2A). Whole-mount X-gal staining
revealed increased signal in the intestines of Lgr5-PKCz/
mice, as compared with Lgr5-PKCzWT/WT mice (Figure 2B).
Histology also demonstrated increased regeneration of the
Lgr5-expressing population in the Lgr5-PKCz/ intestines, as
documented by a strong increase in LacZ-labeled crypt-villus
units (Figures 2C and 2D) and increased number of GFP-positive
cells (Figure 2E). Furthermore, we found that crypt number and
size and villus length were increased in Lgr5-PKCz/ mice as
compared to WT mice after IR (Figures 2F–2I). We also found
increased Ki67 (Figures 2J and 2K) and Sox9 (Figures 2L and
2M) staining in the crypts of Lgr5-PKCz/ intestines as
compared with identically treated Lgr5-PKCzWT/WT mice. These
results are consistent with a specific role for PKCz in the repopu-
lation potential of ISCs.
Selective PKCzDeficiency in Lgr5+ StemCells Promotes
Intestinal Tumorigenesis
Dysregulation of stem cell activity by such as deletion of the tu-
mor suppressor gene Apc has been associated with intestinal
tumorigenesis in several systems (Barker et al., 2009). To deter-
mine whether the selective loss of PKCz in Lgr5+ ISCs enhances
tumor-forming potential from these cells, we crossed Lgr5-
PKCzWT/WT and Lgr5-PKCzfl/fl mice with APCfl/fl mice. These
mice were subsequently injected with tamoxifen as described
in Figure 3A, which generated Lgr5-PKCzWT/WT/APC/ and
Lgr5-PKCz//APC/ mouse lines. Mice of the different geno-
types were then analyzed for tumor formation 16 days postinjec-
tion. Consistent with previously published data (Barker et al.,
2009), the loss of APC in the Lgr5 population efficiently drove
the induction of adenomas in the small intestine (Figure 3B).
Interestingly, the number and size of these tumors were dramat-
ically increased by the simultaneous deletion of APC and PKCz
selectively in Lgr5 stem cells (Figures 3B–3E). In addition, the
lack of PKCz in Lgr5+ cells enhanced tumor aggressiveness.
That is, whereas Lgr5-PKCzWT/WT/APC/ mice only showed
low-grade adenomas with hyperchromatism of nuclei, tumors
generated from Lgr5-PKCz//APC/ mice corresponded to
high-grade adenomas, with nuclear atypia and marked architec-
tural distortion, including some areas consistent with intramu-
cosal adenocarcinoma, characterized by a cribriform pattern of
growth and an expanding-type infiltration into the lamina propria
(Figure 3F). In addition, a similar phenotype was found in thed Lgr5-PKCz/ small intestines 3 days after IR. Scale bars represent 25 mm.
m irradiated Lgr5-PKCzWT/WT and Lgr5-PKCz/ mice.
of at least 20 fields of view per mouse (n = 4 mice). ***p < 0.001.
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Figure 3. PKCz Deletion in Lgr5+ Cells Enhances Intestinal Tumorigenesis
(A) Experimental design.
(B) Tumors (red circles) from Lgr5-PKCzWT/WT/APC/ and Lgr5-PKCz//APC/ 16 days after tamoxifen injection. Scale bars represent 2 mm.
(C) Quantification of the total number of tumors per mouse (n = 7).
(D) Tumor size distribution.
(E) Stratification of number of tumors according to size.
(F) H&E-stained sections of intestine from both genotypes, showing an adenoma with low-grade dysplasia in Lgr5-PKCzWT/WT/APC/ mice (left panels) and
adenomawith high-grade dysplasia or intramucosal adenocarcinoma in Lgr5-PKCz//APC/mice (middle and right panels, respectively). Scale bar represents
50 mm.
(G) H&E staining of colon tumors (yellow dash circles) from both genotypes, showing a large and highly dysplastic tumor in Lgr5-PKCz//APC/ mice as
compared to Lgr5-PKCzWT/WT/APC/ mice. Scale bar represents 50 mm.
(H and I) Tumor numbers (H) and tumor load (I) (n = 7).
(J) GFP staining, labeling Lgr5+ cells, of tumors from both genotypes. Scale bar represents 25 mm.
Results are presented as mean ± SEM. **p < 0.01, ***p < 0.001.
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colon of Lgr5-PKCz//APC/ mice that displayed bigger and
more dysplastic tumors, with increased number and load of co-
lon tumors as compared to Lgr5-PKCzWT/WT/APC/ mice (Fig-
ures 3G–3I). Interestingly, GFP staining, a surrogate marker of
Lgr5+ stem cell activity in these mice, demonstrated that the
loss of PKCz in Lgr5+ cells promotes stem cell activity along
the large part of the tumors whereas Lgr5+ cells that are
WT for PKCz retain the staining in a small population of cells, cor-
responding only with the base of the dysplastic crypts (Fig-
ure 3G). Collectively, these results demonstrate that PKCz
deficiency promotes ISC activity that translates into increased
tumorigenesis.
Low PKCz Expression in Human Colon Adenocarcinoma
Correlates with Stem Cell and YAP/b-Catenin
Signatures
To assess the relevance of these findings to human disease, we
performed gene set enrichment analysis (GSEA) of human colon
adenocarcinoma samples using data obtained from The Cancer
Genome Atlas Network (COAD data set) using the C2 Molecular
Signatures Database (MSigDB, Broad Institute) to find gene
expression signatures that correlated with PKCz expression.
Notably, and consistent with our in vivo mouse model data, we
found that human colon adenocarcinoma tumors with low levels
of PKCzmRNA exhibited transcriptional profiles associated with
an enrichment of stem cell signatures (Figure 4A). Also, PKCz
mRNA levels negatively correlated in these human tumors with
the stem cell marker genes Hopx and Bmi1 (Figure 4B). These
results support the mouse studies demonstrating that PKCz
restrains tumorigenesis by inhibiting ISC activity and are consis-
tent with data showing that patients with low PKCz levels or high
expression of stem cell genes have a significantly worse prog-
nosis (Ma et al., 2013; Merlos-Sua´rez et al., 2011).
To start addressing the potential signaling mechanisms regu-
lated by PKCz in ISCs, we extended the GSEA analysis of the
COAD data set using the C6 MSigDB that includes oncogenic
signatures of signaling pathways deregulated in cancer. Of
potential great relevance, this analysis revealed that low PKCz
expression correlated with enrichment in Yap signaling (Fig-
ure 4C). Furthermore, we found a significant inverse correlation
between PKCz gene expression levels and those of Yap target
genes such as CTGF and Cyr61 (Figure 4D). In addition, colon
adenocarcinoma patients with low PKCz expression displayed
significantly higher levels of Yap (Figure 4D). In line with these re-
sults, GSEA of a transcriptomic profiling of the human colorectal
adenocarcinoma cell line SW480 with knockdown of PKCz
(shPKCz) also identified ‘‘Yap_up’’ as significantly enriched in
PKCz-deficient cells as compared to nontargeted control cells
(shNT) (Figure 4E). This suggests that PKCz’s mechanism of ac-
tion could involve the repression of Yap signaling. Interestingly,
Ingenuity Pathway Analysis of the same transcriptome revealed
that the most significantly enriched genes in PKCz-deficient
SW480 cells as compared to the PKCz-proficient controls fell
in the canonical pathway category of ‘‘Wnt/b-catenin signaling,’’
with significant upregulation of b-catenin target genes (Fig-
ure 4F). Importantly, PKCz levels displayed a significant inverse
correlation with the b-catenin-dependent gene CD44 in human
colon adenocarcinoma tumors (Figure 4G). In addition, these re-Cesults are in good agreement with those obtained in a parallel
effort using small interfering RNA (siRNA) screening to identify
potential targets of PKCz in SW480 cells. Thus, when this
screening was carried with a pooled siRNA library covering
252 components of major oncogenic pathways designed to
identify genes that had a differential impact on the viability of
PKCz-deficient SW480 as compared to shNT control cells, we
found b-catenin as the top hit in the screen (Figure 4H; Table
S1). It should be noted that the Yap pathway was not included
in the siRNA set used in this screening (Table S1). Collectively,
the clinical data, together with the unbiased transcriptomic and
functional genomic approaches, strongly suggest that Yap and
b-catenin are potential targets of PKCz function.
PKCzDeficiencyResults in Enhancedb-Catenin andYap
Signaling
To investigate whether PKCz represses ISC function through the
regulation of b-catenin and Yap signaling, we first determined
the expression of transcripts involved in these pathways upon
deficiency of PKCz in the in vivo mouse models. Notably, we
found that well established target genes of b-catenin and Yap,
including Yap itself, were significantly upregulated in organoids
(Figure 5A), IECs (Figure 5B), and small intestine extracts (Fig-
ure 5C) from PKCz KO mice kept under basal conditions, as
compared with WT controls. Furthermore, analysis of mRNA
levels of Axin-2 and CTGF, targets of b-catenin and Yap, respec-
tively, in the sorted GFP populations of Figure 1B, also revealed
that both transcripts were reduced in the GFPlo population in
which PKCz levels were enriched (Figures 1B and 1C). This is
in keeping with the repression of these pathways by PKCz (Fig-
ure S2A). In addition, PKCz-deficient intestines displayed
increased nuclear Yap staining (Figures 5D and 5E). Likewise,
staining of CD44, a downstream target of the Wnt/b-catenin
pathway, was more intense and widespread in the mutant intes-
tines (Figure 5F). Furthermore, immunoblot analysis showed
increased b-catenin and Yap protein levels in IECs from PKCz
KO mice (Figure 5G). Notably, Yap protein levels were also
increased in IECs from Lgr5-PKCz/ mice, as well as in orga-
noid cultures from PKCz KO mice (Figure 5H). Similar results
were obtained when IECs and tissues from IR-treated mice
were analyzed for expression of Yap- or b-catenin-target genes
(Figures S2B–S2E). Altogether, these results strongly suggest
that PKCz is a direct or indirect negative regulator of b-catenin
and Yap pathways, two important mediators in stem cell
function.
Yap and b-Catenin Are Direct Substrates of PKCz
We next investigated the molecular mechanisms whereby
PKCz specifically represses Yap and b-catenin. First, we found
that PKCz interacted with Yap and b-catenin in cotransfection
experiments (Figures 6A and 6B). Also, in vitro interaction as-
says using purified recombinant proteins demonstrate that
the interaction of PKCz with Yap and b-catenin was direct (Fig-
ure 6C). We also detected this interaction in immunoprecipi-
tates of endogenous proteins (Figure 6D). More importantly,
immunoprecipitation of endogenous PKCz pulled down not
only Yap and b-catenin but also GSK3b and Axin1 (Figure 6D).
These results suggest that PKCz is part of the b-cateninll Reports 10, 740–754, February 10, 2015 ª2015 The Authors 745
Figure 4. PKCz Is Inversely Associated with Stemness and Yap/b-Catenin Signaling in Human Colon Adenocarcinomas
(A) GSEA plots of enrichment in stem cell signatures in low PKCz expressing-tumors from human colon adenocarcinomas from The Cancer Genome Atlas COAD
data set using C2 MSigDB database.
(B) Negative correlation between mRNA levels of PKCz and stem cell markers (Bmi1 and Hopx) in the same data set as in (A).
(legend continued on next page)
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destruction complex in which Axin1 acts as a scaffold protein
orchestrating the phosphorylation and degradation of b-catenin
(Li et al., 2012). To more firmly establish this question, we
treated HEK293T cells with Wnt3a and analyzed the potential
recruitment of PKCz to the Axin complex. It is well established
that cell activation by Wnt results in the degradation of Axin1,
which correlates with b-catenin stabilization (Li et al., 2012;
Mao et al., 2001; Tolwinski et al., 2003). Interestingly, Axin1
was degraded and the coimmunoprecipitation with PKCz and
GSK3b was reduced upon Wnt3a stimulation (Figure 6E). These
results indicate that PKCz is a bona fide component of the
Axin1 complex and therefore could be involved in the regulation
of b-catenin stability and function.
Given that Yap and b-catenin directly bind PKCz, a potential
mechanism whereby PKCz impacts their function could be
through direct phosphorylation. Therefore, we tested whether
Yap and/or b-catenin could be phosphorylated by PKCz, using
an in vitro phosphorylation assay with recombinant PKCz and
purified bacterially expressed Yap and b-catenin. The results
of this experiment demonstrated that in fact Yap and b-catenin
are direct substrates of PKCz (Figures 6F and 6G). To map the
phosphorylated sites in Yap and b-catenin, we used titanium
dioxide (TiO2)-based phosphopetide enrichment on tryptic di-
gests of in vitro phosphorylation reactions followed by high-per-
formance liquid chromatography tandem mass spectrometry
(MS/MS) analysis. Using this approach, we identified S109 and
T110 as major PKCz phosphorylation sites in Yap and several
sites of low abundance that included T119, S163, and S164 (Fig-
ure S3A). To assess the relative contribution of sites S109 and
T110, we performed an ATP analog-based in vitro phosphoryla-
tion assay with PKCz using recombinant WT- or S109A/T110A-
Yap as substrates (Figure 6H). Consistent with MS/MS analysis,
mutation to alanine of these two sites completely abolished Yap
phosphorylation by PKCz. Interestingly, S109 and T110 sites
were highly conserved among species (Figure S3B), which sug-
gested an important role in Yap regulation.
Similar MS/MS analysis to map the sites phosphorylated in
b-catenin by PKCz identified S45 and several sites of low abun-
dance that included S552 and S675 (Figure S3C). S45, along
with S33, S37, and T41 at the amino-terminal region of b-catenin,
conforms to the consensus GSK3 phosphorylation sequence
and, when phosphorylated, is critical for the recognition of b-cat-
enin by the F box protein b-Trcp, which is an essential step for its
ubiquitination and subsequent proteasome-mediated degrada-
tion (Clevers, 2013; Niehrs, 2012). Importantly, phosphorylation
of b-catenin’s S45 precedes, and is required for, subsequent
GSK3-mediated phosphorylation of S33, S37, and T41 and the
ensuing degradation of b-catenin. Interestingly, in vitro phos-(C) GSEA plot of enrichment in Yap signature in low PKCz expressing-tumors fro
(D) Inverse correlation of Yap-related genes in same data set as (A).
(E) GSEA plot of Yap signaling associated with gene expression in shPKCz-SW4
(F) Ingenuity Pathway analysis of the transcriptome of shPKCz-SW480 cells as
gulated in shPKCz-SW480 cells (right panel).
(G) Negative correlation between PKCz and the b-catenin target gene, CD44, in
(H) siRNA screening of genes required for shPKCz-SW480 cell survival compared
gene to derive the Z score. Light red dots, library siRNA pools; light blue dots, nega
control line viability; negative Z values indicate genes preferentially required for s
Cephorylation assays followed by immunoblotting with a specific
anti-phospho-S45-b-catenin antibody confirmed that S45 is a
bona fide phosphorylation site of PKCz in b-catenin (Figure 6I).
More importantly, immunoblotting of IEC extracts from Lgr5-
PKCz/ and WT mice, and organoid extracts from WT and
PKCz KO mice demonstrated that the loss of PKCz resulted in
a profound inhibition of b-catenin phosphorylation at S45,
concomitant with the accumulation of total b-catenin levels (Fig-
ures 6J and 6K). In contrast, analysis of IEC and organoid ex-
tracts revealed that in vivo PKCz deficiency did not inhibit b-cat-
enin phosphorylation at S552 and S675 (Figures 6J and 6K),
consistent with the finding that these sites were found in low
abundance in the MS/MS proteomic analysis in vitro.
PKCz Regulates Protein Stability and Function of Yap
and b-Catenin by Phosphorylation
To determine the functional relevance of Yap and b-catenin
phosphorylation by PKCz, either WT or the nonphosphorylatable
Yap S109A/T110A mutant was expressed along with increasing
amounts PKCz, after which we assessed the effect of PKCz
expression on the activity of Yap by using a TEAD-luciferase re-
porter. Notably, expression of either WT or mutant Yap was able
to activate the TEAD-luciferase reporter to a similar extent
(Figure 7A). However, the coexpression of PKCz resulted in
inhibition of the TEAD-reporter activity induced by WT Yap, but
not by mutant Yap (Figure 7A). This demonstrates that Yap
function is directly regulated by phosphorylation in residues
S109/T110.
Of note, Yap function is restrained through phosphorylation by
the Hippo kinases Mst1/2 and Lats (Barry and Camargo, 2013;
Mo et al., 2014). Therefore, we tested whether Yap constructs
containing mutations in the Mst or Lats phosphorylation sites,
termed 2SA (S127/381A) and Yap5SA (S61/109/127/164/381),
were also sensitive to PKCz’s actions. Results of Figure S4A
demonstrate that overexpression of PKCz was able to restrain
TEAD-activity induced by Yap2SA with no effect on the activity
of Yap5SA (Figure S4A). These data are consistent with the
fact that the S109 phosphorylation site by PKCz is also mutated
in the Yap5SA mutant, but not in the Yap2SA mutant, further re-
inforcing the notion that PKCz targets Yap at S109/T110 and in a
manner that is likely independent of the Hippo/Mst cascade.
Collectively, these results are consistent with our in vivo data
shown above (Figures 5A–5D), demonstrating that PKCz defi-
ciency resulted in increased Yap activity.
Interestingly, the levels ofWTYap, but not of the S109A/T110A
mutant, were decreased by coexpression of PKCz (Figure 7A),
demonstrating that this kinase regulates Yap transcriptional ac-
tivity by controlling Yap levels through direct phosphorylation.m COAD data set using C6 MSigDB database.
80 cells (GSE42186).
compared to shNT control cells (left panel). Wnt/b-catenin target genes upre-
the COAD data set.
to shNT cells. A differential viability ratio shPKCz/NT was computed for each
tive control pool. Positive Z values indicate genes preferentially required for the
hPKCz line viability. List of highly significant hits are shown. See also Table S1.
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Figure 5. PKCz Deficiency Results in Enhanced b-Catenin and Yap Signaling
(A–C) mRNA levels of Wnt/b-catenin- and Yap-related genes in crypt organoids (n = 3) after 3 days in culture (A), isolated intestinal epithelial cells (IECs) (n = 6) (B),
and small intestine (n = 6) of WT and PKCz KO mice (C).
(D and E) Yap staining (D) and quantification (E) in small intestine from WT and PKCz KO mice (n = 6).
(F) CD44 staining of small intestine from WT and PKCz KO mice (n = 6).
(legend continued on next page)
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This is consistent with our observations that Yap itself was upre-
gulated in PKCz-deficient tissues in vivo (Figures 5D–5H). In
keeping with this conclusion, the S109A/T110A Yap mutant
was significantly more stable than WT Yap in cycloheximide-
treated cells (Figure 7B), lending support to our hypothesis that
PKCz represses Yap function by promoting its destabilization
through direct phosphorylation of residues S109 and T110.
Next, we determined the functional relevance of b-catenin phos-
phorylation at S45 by PKCz. Thus, we analyzed the effect of
PKCz knockdown on b-catenin-induced transcriptional activity
of a specific luciferase reporter construct termed TOPflash. In
support of our hypothesis that PKCz is a negative regulator of
theWnt pathway, the ability of b-catenin to activate the TOPflash
reporter was enhanced by PKCz knockdown (Figure 7C). In addi-
tion, expression of PKCz in cotransfection experiments resulted
in the inhibition of TOPflash activity induced byWT b-catenin, but
not by that of an S45A mutant, which correlated with decreased
levels of WT b-catenin, but not the mutant protein, in the PKCz-
expressing samples (Figures 7D and 7E). Collectively, these re-
sults establish PKCz as a negative regulator of b-catenin stability
by phosphorylation of S45. Since this site has been shown to be
a target of CKIa (Clevers et al., 2014; Niehrs, 2012), we next
determined whether its in vivo phosphorylation by PKCz is medi-
ated byCKIa. Interestingly, PKCz-induced depletion of b-catenin
levels in vivo was not affected by the knockdown of CKIa (Fig-
ure S4B). These results establish that S45 is a direct target of
PKCz in a CKIa-independent fashion.
Further supporting the functional relevance of PKCz regulation
of b-catenin and Yap, we found that PKCz knockdown in SW480
colorectal carcinoma cells promotes the activation of the b-cat-
enin and Yap reporters (Figures 7F and 7G). Notably, this corre-
lated with increased levels of both transcriptional regulators in
the PKCz-deficient cells (Figure 7H). Our previous studies in
this system revealed the critical role of PKCz as a tumor suppres-
sor in cancer cells undergoing nutrient stress (Ma et al., 2013).
Therefore, we hypothesized that PKCz is a signaling molecule
in the repression of both b-catenin and Yap in response to
nutrient deprivation. Interestingly, incubation of PKCz-proficient
SW480 cells under nutrient stress conditions inhibited the nu-
clear localization of b-catenin and Yap (Figure 7I). Importantly,
this effect was completely abrogated in PKCz-deficient SW480
cells (Figure 7I). Consistently, the levels of b-catenin and Yap
downstream transcripts were higher in PKCz-deficient SW480
cells under stress conditions than in the shNT controls (Fig-
ure S4C). Furthermore, knockdown of b-catenin or Yap inhibited
the increased proliferation and survival of PKCz-deficient SW480
cells (Figure S4D). In order to establish the in vivo contribution
of the b-catenin and Yap pathways to the mechanism of action
of PKCz, we treated organoids from WT and PKCz KO mice
with verteporfin, which inhibits Yap function by disrupting the
Yap-TEAD interaction, or with a combination of DKK1 plus
Iwr1, which are inhibitors of the Wnt cascade. Consistent with(G) Western blot of nuclear b-catenin or Yap levels of IECs from WT and PKCz K
(H)Western blot of Yap levels in extracts from Lgr5-PKCzWT/WT and Lgr5-PKCz/
KO mice.
Scale bars represent 25 mm. Results are representative of three experiments. Res
Figure S2.
Ceour hypothesis, the inhibition of both pathways rescued the
phenotype of PKCz KO organoids (Figures 7J–7L).
DISCUSSION
The identification of Lgr5+ cells as an ISC population has
expanded our understanding of the intestinal regeneration pro-
cesses induced in response to acute injury and opens up new
avenues for research on the role and mechanisms of action of
the stem cells in cancer initiation (Barker et al., 2009). Since
the intestinal epithelium has an inherently high cellular turnover,
fueled by the activity of ISCs residing at the bottom of the crypts,
it is difficult to envision how mutations could be passed along
through successive generations if stem-cell-derived differenti-
ated cells undergo apoptosis with a high frequency after terminal
differentiation and are substituted by new epithelial cells. The ex-
istence of a pool of stem cells that could accumulate these mu-
tationsmight account for the generation of tumors in the intestine
andmight offer possibilities for treatment as well as strategies for
prevention of tumor initiation by blocking those pathways that
are critical for the control of the stem-cell-driven carcinogenesis
process (Anastas and Moon, 2013; Vermeulen and Snippert,
2014). Understanding the biochemistry and signaling properties
of these intestinal Lgr5+ stem cells will be instrumental in
designing better strategies not only to prevent cancer but also
to promote intestinal regeneration after acute or chronic dam-
age, such as that triggered by chemoradiotherapies. Our recent
results demonstrate that PKCz is a suppressor of tumor progres-
sion in intestinal carcinogenesis because it represses the ability
of aggressive cancer cells to reprogram their metabolism under
situations of nutrient stress in mouse and human cancers (Ma
et al., 2013). We show here that PKCz deficiency leads to greater
levels of stem cell activity in vitro and in vivo, which triggers
an enhanced regenerative response to acute intestinal insults.
Loss of PKCz also results in greater tumorigenic activity
of the stem cell population in the absence of the tumor
suppressor APC.
Although several signaling pathways are involved in intestine
homeostasis and regeneration, including, BMP, Shh, and
Notch, Wnt signaling has attracted great attention due to the
fact that it is the target of several cancer-driving mutations
(Clevers et al., 2014). Also, the Wnt/b-catenin cascade has
been shown to be critical for the proliferation of ISCs and TA
cells, as revealed by the lack of proliferative crypts in mice
with deletion of its transcriptional partner Tcf4 (Korinek et al.,
1998). b-Catenin is the effector of the Wnt pathway and is asso-
ciated with, and degraded by, the APC/Axin/GSK3b complex
(Clevers et al., 2014; Niehrs, 2012). Phosphorylation of b-cate-
nin initially at S45 is a necessary event for GSK3b to sequen-
tially phosphorylate residues S33, S37, and T41, creating a
recognition motif for the E3-ligase b-Trcp that constitutively tar-
gets b-catenin for degradation (Clevers et al., 2014; Niehrs,O mice (n = 3).
mice 10 days after tamoxifen injection, and crypt organoids fromWT and PKCz
ults are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also
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Figure 6. Yap and b-Catenin Are Direct Substrates of PKCz
(A and B) Interaction of PKCz with Yap (A) and b-catenin (B) in cotransfection experiments in HEK293T cells.
(C) In vitro interaction of recombinant PKCz with recombinant Yap and b-catenin.
(D) Endogenous interaction of PKCz and components of Axin1 complex in HEK293T cells.
(E) Endogenous association of Axin1 with PKCz and GSK3b in Wnt3a-treated HEK293T cells.
(F and G) In vitro phosphorylation of Yap (F) and b-catenin (G) by PKCz with [g-32P]-ATP.
(H) Western blot of thiophosphate ester after YAP phosphorylation by PKCz with ATPgS.
(legend continued on next page)
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2012). Upon stimulation of the pathway, these phosphorylation
events and the subsequent degradation of b-catenin are
impaired, and b-catenin thus accumulates in the nucleus and
activates the transcription of several critical components of
the proliferation and stem cell activity (Clevers et al., 2014;
Niehrs, 2012). Interestingly, we show here that PKCz’s role as
a suppressor of tumorigenesis and ISC activity is mediated by
the direct phosphorylation of S45 in a CKIa-independent
manner. Upon PKCz inactivation, which is common in human
intestinal cancers and results in enhanced tumorigenesis in
several mouse models (Ma et al., 2013), b-catenin becomes
more stable and accumulates in the nucleus of intestinal epithe-
lial and stem cells.
Along with Wnt/b-catenin, Yap has been proposed as an
important regulator of ISC function (Clevers et al., 2014; Harvey
et al., 2013; Mo et al., 2014). Yap is directly phosphorylated by
the kinases Lats1/2 that are under regulation of the tumor sup-
pressor Hippo pathway that includes the kinases Mst1 and
Mst2 and the adaptor Sav1 (Harvey et al., 2013; Mo et al.,
2014). Lats1/2-mediated phosphorylation of Yap S127 serves
to promote its exclusion from the nucleus and its eventual degra-
dation. Yap is expressed in both the small intestine and colon,
displaying cytoplasmic localization in the upper regions of the
crypt and villi whereas it is nuclear in the Lgr5+ ISCs (Barry and
Camargo, 2013). Even though the deletion of Yap has no signif-
icant effects on intestinal cell proliferation or function (Cai et al.,
2010; Zhou et al., 2011), possibly due to the compensatory ac-
tions of Taz, its endogenous activation by inhibition of different
components of the Hippo pathway in the intestine results in
increased proliferation and tumorigenesis. That is, although
overexpression Yap experiments in vivo gave contradictory re-
sults (Barry and Camargo, 2013; Li and Clevers, 2010), experi-
ments modulating the endogenous levels of Yap strongly sup-
port its positive role in intestinal epithelial cell proliferation.
Thus, deletion of both Mst1 and Mst2, whose role is to repress
Yap function in the Hippo pathway, in the mouse intestine leads
to crypt dysplasia in a Yap-dependent manner (Zhou et al.,
2011). Furthermore, intestine-specific deletion of Sav1 in mice,
which correlates with Yap activation, also leads to crypt hyper-
plasia with highly proliferating cells, a phenotype that is rescued
by the concomitant inactivation of Yap (Cai et al., 2010). The link
of Yap with intestinal cancer is apparent, since both double
MST1/2 and Sav1 KO mice develop various forms of intestinal
tumorigenesis (Cai et al., 2010; Zhou et al., 2011). Moreover,
Yap and Taz expression is increased in colorectal cancer
(CRC) patients (Cai et al., 2010; Steinhardt et al., 2008; Wang
et al., 2013; Zhou et al., 2011), and it has been shown that Yap
promotes resistance of CRC cells to chemotherapy (Touil
et al., 2014). Therefore, our data shown here, demonstrating
that PKCz, in addition to interacting with and phosphorylating
b-catenin at S45, also binds Yap and promotes its phosphoryla-
tion at S109/T110 to impair its stability, is of great relevance in
ISC function.(I) Western blot of S45-b-catenin phosphorylated by PKCz in vitro.
(J and K) Western blot of b-catenin phosphorylation in IECs from Lgr5-PKCzWT/
mice (K).
Results are representative of three experiments. See also Figure S3.
CeThe fact that PKCz impinges in both pathways is of particular
interest given the existence of a previously described crosstalk
between Yap and b-catenin. In this regard, several studies
have reported the interaction of Yap with different components
of theWnt pathway, including Dvl, Axin1, and b-catenin itself (Az-
zolin et al., 2014; Barry et al., 2013; Rosenbluh et al., 2012). The
interaction with b-catenin is interesting because of the available
data showing that Yap and b-catenin interact to promote cell sur-
vival and transformation of colon cancer cells (Rosenbluh et al.,
2012). Since PKCz destabilizes both b-catenin and Yap levels
and inhibits their transcriptional activity even when overex-
pressed, a situation that mimics their activation state, this sug-
gests that PKCz actions will be relevant not only during b-catenin
regulation by the destruction complex but also once this is in-
hibited. More interestingly, we show here that PKCz immunopre-
cipitation pulls down not only b-catenin and Yap but also Axin1,
indicating that PKCz is also part of the destruction complex.
Interestingly, recently published data showed that Yap/Taz are
essential for the recruitment of b-TrCP to the Axin1 complex
and subsequent b-catenin inactivation in cells under conditions
of inactive Wnt (Azzolin et al., 2014). When cells are activated
by Wnt, Yap/Taz are released from the complex and translo-
cated to the nucleus (Azzolin et al., 2014). Under these condi-
tions, bTrCP cannot be recruited to the complex and b-catenin,
although phosphorylated, cannot be polyubiquitinated and
degraded, clogging the destruction complex, which allows
newly synthesized b-catenin to be translocated to the nucleus
(Azzolin et al., 2014). Interestingly, cell stimulation with Wnt
also promotes the degradation of Axin1 and therefore dislodges
the destruction complex including the association with PKCz
(Figures 6D and 6E). However, since PKCz directly binds b-cat-
enin and Yap, this suggests that it regulates their stability prob-
ably when it is part of the destruction complex and also when
released from Axin1, constituting an additional layer of control
for b-catenin and Yap levels and functions.
In addition, our previously published data demonstrated that
PKCz is part of a stress response triggered by nutrient depriva-
tion, whereby PKCz’s role is to restrain survival of CRC cells un-
der these conditions (Ma et al., 2013). In the present study, we
show that PKCz deficiency prevents the inactivation of b-catenin
and Yap by nutrient stress. This is in keeping with very recently
reported evidence demonstrating that the Yap pathway is in-
hibited by energy stress through AMPK and the phosphorylation
of AMOTL1 (DeRan et al., 2014). These results, together with our
data, indicate that Yap and b-catenin are exquisitely regulated
during situations of nutrient deprivation to ensure that these
pathways are not activated when stem cells do not have the
necessary conditions to survive when activated. As PKCz is a
tumor suppressor, our model suggests that its role is to block
tumorigenesis by preventing metabolic reprogramming under
conditions of nutrient deprivation and by inhibiting the activation
of b-catenin and Yap to block the stem cell activation programs,
specially under conditions of stress.WT and Lgr5-PKCz/ mice (J) and in crypt organoids from WT and PKCz KO
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Figure 7. PKCz Regulates the Stability and Function of Yap and b-Catenin
(A) TEAD luciferase assay in HEK293T cells cotransfected with the indicated expression plasmids. Luciferase activity was normalized to Renilla activity.
(B) HEK293T cells transfected with S109A/T110A Yap mutant or WT Yap were incubated with cycloheximide, and protein stability was determined by immu-
noblot. Yap protein levels were normalized to actin.
(C) TOPflash-luciferase assay in shNT or shPKCz-HEK293T cells cotransfected with Flag-b-catenin. Luciferase activity was normalized to Renilla activity (n = 3).
(D and E) TOPflash-luciferase assay in HEK293T cells co-transfected with the indicated expression plasmids. Luciferase activity was normalized to Renilla activity
(n = 3).
(F and G) TOPflash (F) and TEAD (G) luciferase assays in shNT- or shPKCz-SW480 cells. Luciferase activity was normalized to Renilla activity (n = 3).
(H) Western blot of extracts from shNT and shPKCz SW480 cells.
(legend continued on next page)
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EXPERIMENTAL PROCEDURES
Mice
Animal handling and experimental procedures conformed to institutional
guidelines (Sanford-Burnham Medical Research Institute Institutional Ani-
mal Care and Use Committee). PKCzfl/fl (Prkcztm1a(EUCOMM)Wtsi) mice were
obtained from the International Knockout Mouse Consortium and gener-
ated for the EUCOMM project by the Wellcome Trust Sanger Institute.
Please see the Supplemental Experimental Procedures for more detailed
protocols.
IEC Isolation
Isolation of IECs was carried out as described previously (Egan et al., 2004).
Statistical Analysis
Data are presented as the mean ± SEM. Significant differences between
groups were determined with a Student’s t test (two tailed). The significance
level for statistical testing was set at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.01.007.
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